查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1360312

毒理學藥物測試市場 - 2023-2031 年全球產業分析、規模、佔有率、成長、趨勢和預測

Toxicology Drug Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

毒理學藥物測試市場 - 報告範圍

TMR 關於全球毒理學藥物測試市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球毒理學藥物測試的收入2017- 2031年期間的市場，考慮2023年為基準年，2031年為預測年。報告中也提供了2023年至2031年全球毒理學藥物測試市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解毒理學藥物測試市場。

市場概況
2023年市場價值 347 億美元
2031 年市場價值 557 億美元
年複合成長率 5.5%

該報告深入探討了全球毒理學藥物測試市場的競爭格局。全球毒理學藥物測試市場的主要參與者已被確定，並且每一位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球毒理學藥物測試市場參與者的屬性。

目錄

第 1 章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 技術進步
  • 按地區/全球分類的監管情景
  • COVID-19 大流行對產業的影響（價值鍊和短期/中期/長期影響）

第 6 章：全球市場分析與預測：按測試類型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依測試類型，2017-2031
    • 體外
    • 體內
    • 電腦模擬
  • 市場吸引力分析：按測試類型

第 7 章：全球市場分析與預測：透過測試方法

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依測試方法，2017-2031
    • 質譜成像
    • 電子顯微鏡
    • 螢光標記
    • 免疫組織化學
    • 其他
  • 市場吸引力分析：透過測試方法

第 8 章：全球市場分析與預測：按應用分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依應用分類，2017-2031
    • 藥物開發
    • 藥物濫用和成癮
    • 治療藥物監測
    • 其他
  • 市場吸引力分析：按應用

第 9 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2017-2031
    • 化妝品產業
    • 醫療保健產業
      • 醫院和診所
      • 診斷實驗室
      • 製藥與生物技術公司
      • 其他
    • 食品工業
    • 化工行業
  • 市場吸引力分析：按最終用戶

第 10 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2017-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 按國家/地區分類的市場吸引力

第 11 章：北美市場分析與預測

第 12 章：歐洲市場分析與預測

第 13 章：亞太市場分析與預測

第 14 章：拉丁美洲市場分析與預測

第 15 章：中東和非洲市場分析與預測

第16章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • TDAL Labs
    • Thermo Fisher Scientific Inc.
    • Abbott
    • Icahn School of Medicine at Mount Sinai
    • Clinisys, Inc.
    • Laboratory Corporation of America Holdings
    • SLUCARE
    • Keystone Lab
    • Shimadzu Scientific Instruments
    • Ganesh Diagnostic & Imaging Centre Pvt. Ltd.
    • Other Players
Product Code: TMRGL85789

Toxicology Drug Testing Market - Scope of Report

TMR's report on the global toxicology drug testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global toxicology drug testing market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global toxicology drug testing market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the toxicology drug testing market.

Market Snapshot
Market Value in 2023US$ 34.7 Bn
Market Value in 2031US$ 55.7 Bn
CAGR5.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global toxicology drug testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global toxicology drug testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global toxicology drug testing market.

The report delves into the competitive landscape of the global toxicology drug testing market. Key players operating in the global toxicology drug testing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global toxicology drug testing market profiled in this report.

Key Questions Answered in Global Toxicology Drug Testing Market Report:

  • What is the sales/revenue generated by toxicology drug testing across all regions during the forecast period?
  • What are the opportunities in the global toxicology drug testing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Toxicology Drug Testing Market - Research Objectives and Research Approach

The comprehensive report on the global toxicology drug testing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global toxicology drug testing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global toxicology drug testing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Toxicology Drug Testing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Toxicology Drug Testing Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Regulatory Scenario by Region/Globally
  • 5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Toxicology Drug Testing Market Analysis and Forecast, by Testing Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Testing Type, 2017-2031
    • 6.3.1. In Vitro
    • 6.3.2. In Vivo
    • 6.3.3. In Silico
  • 6.4. Market Attractiveness Analysis, by Testing Type

7. Global Toxicology Drug Testing Market Analysis and Forecast, by Testing Method

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Testing Method, 2017-2031
    • 7.3.1. Mass Spectrometry Imaging
    • 7.3.2. Electron Microscopy
    • 7.3.3. Fluorescence Labeling
    • 7.3.4. Immunohistochemistry
    • 7.3.5. Others
  • 7.4. Market Attractiveness Analysis, by Testing Method

8. Global Toxicology Drug Testing Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2017-2031
    • 8.3.1. Drug Development
    • 8.3.2. Substance Abuse and Addiction
    • 8.3.3. Therapeutic Drug Monitoring
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Toxicology Drug Testing Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Cosmetics Industry
    • 9.3.2. Healthcare Industry
      • 9.3.2.1. Hospital and Clinics
      • 9.3.2.2. Diagnostic Laboratories
      • 9.3.2.3. Pharmaceutical & Biotechnology Companies
      • 9.3.2.4. Others
    • 9.3.3. Food Industry
    • 9.3.4. Chemicals Industry
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Toxicology Drug Testing Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Toxicology Drug Testing Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Testing Type, 2017-2031
    • 11.2.1. In Vitro
    • 11.2.2. In Vivo
    • 11.2.3. In Silico
  • 11.3. Market Value Forecast, by Testing Method, 2017-2031
    • 11.3.1. Mass Spectrometry Imaging
    • 11.3.2. Electron Microscopy
    • 11.3.3. Fluorescence Labeling
    • 11.3.4. Immunohistochemistry
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by Application, 2017-2031
    • 11.4.1. Drug Development
    • 11.4.2. Substance Abuse and Addiction
    • 11.4.3. Therapeutic Drug Monitoring
    • 11.4.4. Others
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Cosmetics Industry
    • 11.5.2. Healthcare Industry
      • 11.5.2.1. Hospital and Clinics
      • 11.5.2.2. Diagnostic Laboratories
      • 11.5.2.3. Pharmaceutical & Biotechnology Companies
      • 11.5.2.4. Others
    • 11.5.3. Food Industry
    • 11.5.4. Chemicals Industry
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Testing Type
    • 11.7.2. By Testing Method
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country/Sub-region

12. Europe Toxicology Drug Testing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Testing Type, 2017-2031
    • 12.2.1. In Vitro
    • 12.2.2. In Vivo
    • 12.2.3. In Silico
  • 12.3. Market Value Forecast, by Testing Method, 2017-2031
    • 12.3.1. Mass Spectrometry Imaging
    • 12.3.2. Electron Microscopy
    • 12.3.3. Fluorescence Labeling
    • 12.3.4. Immunohistochemistry
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by Application, 2017-2031
    • 12.4.1. Drug Development
    • 12.4.2. Substance Abuse and Addiction
    • 12.4.3. Therapeutic Drug Monitoring
    • 12.4.4. Others
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Cosmetics Industry
    • 12.5.2. Healthcare Industry
      • 12.5.2.1. Hospital and Clinics
      • 12.5.2.2. Diagnostic Laboratories
      • 12.5.2.3. Pharmaceutical & Biotechnology Companies
      • 12.5.2.4. Others
    • 12.5.3. Food Industry
    • 12.5.4. Chemicals Industry
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Testing Type
    • 12.7.2. By Testing Method
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Toxicology Drug Testing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Testing Type, 2017-2031
    • 13.2.1. In Vitro
    • 13.2.2. In Vivo
    • 13.2.3. In Silico
  • 13.3. Market Value Forecast, by Testing Method, 2017-2031
    • 13.3.1. Mass Spectrometry Imaging
    • 13.3.2. Electron Microscopy
    • 13.3.3. Fluorescence Labeling
    • 13.3.4. Immunohistochemistry
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by Application, 2017-2031
    • 13.4.1. Drug Development
    • 13.4.2. Substance Abuse and Addiction
    • 13.4.3. Therapeutic Drug Monitoring
    • 13.4.4. Others
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Cosmetics Industry
    • 13.5.2. Healthcare Industry
      • 13.5.2.1. Hospital and Clinics
      • 13.5.2.2. Diagnostic Laboratories
      • 13.5.2.3. Pharmaceutical & Biotechnology Companies
      • 13.5.2.4. Others
    • 13.5.3. Food Industry
    • 13.5.4. Chemicals Industry
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Testing Type
    • 13.7.2. By Testing Method
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Toxicology Drug Testing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Testing Type, 2017-2031
    • 14.2.1. In Vitro
    • 14.2.2. In Vivo
    • 14.2.3. In Silico
  • 14.3. Market Value Forecast, by Testing Method, 2017-2031
    • 14.3.1. Mass Spectrometry Imaging
    • 14.3.2. Electron Microscopy
    • 14.3.3. Fluorescence Labeling
    • 14.3.4. Immunohistochemistry
    • 14.3.5. Others
  • 14.4. Market Value Forecast, by Application, 2017-2031
    • 14.4.1. Drug Development
    • 14.4.2. Substance Abuse and Addiction
    • 14.4.3. Therapeutic Drug Monitoring
    • 14.4.4. Others
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Cosmetics Industry
    • 14.5.2. Healthcare Industry
      • 14.5.2.1. Hospital and Clinics
      • 14.5.2.2. Diagnostic Laboratories
      • 14.5.2.3. Pharmaceutical & Biotechnology Companies
      • 14.5.2.4. Others
    • 14.5.3. Food Industry
    • 14.5.4. Chemicals Industry
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Testing Type
    • 14.7.2. By Testing Method
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Toxicology Drug Testing Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Testing Type, 2017-2031
    • 15.2.1. In Vitro
    • 15.2.2. In Vivo
    • 15.2.3. In Silico
  • 15.3. Market Value Forecast, by Testing Method, 2017-2031
    • 15.3.1. Mass Spectrometry Imaging
    • 15.3.2. Electron Microscopy
    • 15.3.3. Fluorescence Labeling
    • 15.3.4. Immunohistochemistry
    • 15.3.5. Others
  • 15.4. Market Value Forecast, by End-user, 2017-2031
    • 15.4.1. Drug Development
    • 15.4.2. Substance Abuse and Addiction
    • 15.4.3. Therapeutic Drug Monitoring
    • 15.4.4. Others
  • 15.5. Market Value Forecast, by Application, 2017-2031
    • 15.5.1. Cosmetics Industry
    • 15.5.2. Healthcare Industry
      • 15.5.2.1. Hospital and Clinics
      • 15.5.2.2. Diagnostic Laboratories
      • 15.5.2.3. Pharmaceutical & Biotechnology Companies
      • 15.5.2.4. Others
    • 15.5.3. Food Industry
    • 15.5.4. Chemicals Industry
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Testing Type
    • 15.7.2. By Testing Method
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. TDAL Labs
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Thermo Fisher Scientific Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Abbott
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Icahn School of Medicine at Mount Sinai
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Clinisys, Inc.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Laboratory Corporation of America Holdings
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. SLUCARE
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Keystone Lab
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Shimadzu Scientific Instruments
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Ganesh Diagnostic & Imaging Centre Pvt. Ltd.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Other Players
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview

List of Tables

  • Table 01: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
  • Table 02: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
  • Table 03: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 04: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
  • Table 06: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
  • Table 08: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
  • Table 09: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 10: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
  • Table 12: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 13: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
  • Table 14: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
  • Table 15: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
  • Table 18: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 19: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
  • Table 20: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
  • Table 21: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 22: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 23: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
  • Table 24: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 25: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
  • Table 26: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
  • Table 27: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 28: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 29: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
  • Table 30: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 31: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
  • Table 32: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
  • Table 33: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 34: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 35: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
  • Table 36: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

  • Figure 01: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
  • Figure 03: Global Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
  • Figure 04: Global Toxicology Drug Testing Market Revenue (US$ Mn), by In Vitro, 2017-2031
  • Figure 05: Global Toxicology Drug Testing Market Revenue (US$ Mn), by In Vivo, 2017-2031
  • Figure 06: Global Toxicology Drug Testing Market Revenue (US$ Mn), by In Silico, 2017-2031
  • Figure 07: Global Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
  • Figure 08: Global Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
  • Figure 09: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Mass Spectrometry Imaging, 2017-2031
  • Figure 10: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Electron Microscopy, 2017-2031
  • Figure 11: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Fluorescence Labeling, 2017-2031
  • Figure 12: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Immunohistochemistry, 2017-2031
  • Figure 13: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 14: Global Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 15: Global Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 16: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Drug Development, 2017-2031
  • Figure 17: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Substance Abuse and Addiction, 2017-2031
  • Figure 18: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Therapeutic Drug Monitoring, 2017-2031
  • Figure 19: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 20: Global Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 21: Global Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 22: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Cosmetics Industry, 2017-2031
  • Figure 23: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Healthcare Industry, 2017-2031
  • Figure 24: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Food Industry, 2017-2031
  • Figure 25: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Chemicals Industry, 2017-2031
  • Figure 26: Global Toxicology Drug Testing Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 27: Global Toxicology Drug Testing Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 28: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 29: North America Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
  • Figure 30: North America Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
  • Figure 31: North America Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
  • Figure 32: North America Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
  • Figure 33: North America Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 34: North America Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 35: North America Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 36: North America Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 37: North America Toxicology Drug Testing Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 38: North America Toxicology Drug Testing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 39: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 40: Europe Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
  • Figure 41: Europe Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
  • Figure 42: Europe Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
  • Figure 43: Europe Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
  • Figure 44: Europe Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 45: Europe Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 46: Europe Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 47: Europe Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 48: Europe Toxicology Drug Testing Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 49: Europe Toxicology Drug Testing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 50: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 51: Asia-Pacific Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
  • Figure 52: Asia-Pacific Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
  • Figure 53: Asia-Pacific Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
  • Figure 54: Asia-Pacific Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
  • Figure 55: Asia-Pacific Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 56: Asia-Pacific Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 57: Asia-Pacific Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 58: Asia-Pacific Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 59: Asia-Pacific Toxicology Drug Testing Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 60: Asia-Pacific Toxicology Drug Testing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 61: Asia-Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 62: Latin America Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
  • Figure 63: Latin America Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
  • Figure 64: Latin America Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
  • Figure 65: Latin America Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
  • Figure 66: Latin America Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 67: Latin America Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 68: Latin America Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 69: Latin America Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 70: Latin America Toxicology Drug Testing Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 71: Latin America Toxicology Drug Testing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 72: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 73: Middle East & Africa Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
  • Figure 74: Middle East & Africa Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
  • Figure 75: Middle East & Africa Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
  • Figure 76: Middle East & Africa Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
  • Figure 77: Middle East & Africa Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 78: Middle East & Africa Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 79: Middle East & Africa Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 80: Middle East & Africa Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 81: Middle East & Africa Toxicology Drug Testing Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 82: Middle East & Africa Toxicology Drug Testing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 83: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031